Journal of Carcinogenesis & Mutagenesis

Role of Tumor Suppressor Genes in Carcinogenesis

Caelan Veris^* Department of Molecular Carcinogenesis Helixon Institute of Biomedical Research Vienna, Austria
^*Correspondence: Caelan Veris, Department of Molecular Carcinogenesis Helixon Institute of Biomedical Research Vienna, Austria, Email:

Received: 27-Apr-2026, Manuscript No. JCM-26-31974; Editor assigned: 29-Apr-2026, Pre QC No. JCM-26-31974 (PQ); Reviewed: 13-May-2026, QC No. JCM-26-31974; Revised: 20-May-2026, Manuscript No. JCM-26-31974 (R); Published: 27-May-2026, DOI: 10.35248/2157-2518.26.17.509

Description

Tumor suppressor genes are essential components of the human genome that protect cells from uncontrolled growth and malignant transformation. These genes function as the natural defense system against cancer by regulating cell proliferation, maintaining genomic stability, repairing damaged Deoxyribonucleic Acid (DNA) and promoting programmed cell death when cellular damage becomes irreparable. Under normal physiological conditions, tumor suppressor genes ensure that cells divide only when necessary and prevent the accumulation of harmful genetic alterations. When these genes become inactivated through mutations, deletions, epigenetic silencing, or chromosomal abnormalities, their protective functions are lost, allowing abnormal cells to proliferate and eventually develop into cancer. The study of tumor suppressor genes has significantly enhanced the understanding of carcinogenesis and has provided valuable insights into cancer prevention, diagnosis, prognosis and targeted therapeutic development.

Unlike oncogenes, which promote cancer when activated, tumor suppressor genes contribute to cancer development primarily through loss of function. Most tumor suppressor genes follow the "two-hit hypothesis," which proposes that both copies of the gene must be inactivated before the protective effect is lost. The first alteration may be inherited or acquired during an individual's lifetime, while the second usually occurs through somatic mutation, deletion, or epigenetic modification. Once both alleles become nonfunctional, the affected cell loses an important regulatory mechanism that normally prevents excessive proliferation and genomic instability. This concept explains why inherited mutations in tumor suppressor genes substantially increase susceptibility to several hereditary cancer syndromes.

Tumor suppressor genes perform diverse biological functions that are important for maintaining cellular homeostasis. One of their primary roles is regulating the cell cycle by controlling progression through different phases of cell division. These genes monitor whether DNA replication has occurred correctly before permitting further cell division. If DNA damage is detected, tumor suppressor proteins activate cell cycle checkpoints that temporarily halt proliferation, allowing repair mechanisms to correct the damage. If the damage cannot be repaired successfully, these genes may initiate apoptosis, thereby eliminating potentially dangerous cells before they become malignant. This coordinated regulation helps preserve tissue integrity and minimizes the accumulation of cancer-promoting mutations.

Several well-characterized tumor suppressor genes illustrate their importance in cancer prevention. TP53, often referred to as the "guardian of the genome," is one of the most extensively studied tumor suppressor genes. It responds to cellular stress by regulating DNA repair, cell cycle arrest, senescence and apoptosis. Mutations affecting Tumor Protein53 (TP53) are among the most common genetic alterations observed in human cancers and are associated with poor prognosis in many malignancies. The RetinoBlastoma1 (RB1) gene regulates the transition from the G1 phase to the S phase of the cell cycle, preventing inappropriate cellular proliferation. Inactivation of RB1 contributes to retinoblastoma and several other cancers. BReast CAncer gene1 (BRCA1) and BReast CAncer gene2 (BRCA2) participate in high-fidelity DNA repair through homologous recombination and inherited mutations in these genes significantly increase the lifetime risk of breast, ovarian, prostate and pancreatic cancers.

Conclusion

Tumor suppressor genes are indispensable guardians of genomic integrity that prevent malignant transformation by regulating cell proliferation, repairing DNA damage and eliminating genetically compromised cells. Their inactivation represents a fundamental event in the development of many human cancers and often cooperates with oncogene activation to drive tumor progression. Continued research into the biology of tumor suppressor genes, combined with advances in molecular diagnostics and precision medicine, will enhance early detection, improve risk assessment and support the development of more effective therapeutic strategies, ultimately contributing to better outcomes for individuals affected by cancer.